XML 54 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 90,840 $ 88,647 $ 178,823 $ 173,591
Net investment income (loss) 394 274 848 608
Total revenues 91,234 88,921 179,671 174,199
Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 50,980 55,062 99,377 107,847
Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,281 5,629 10,651 11,226
Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 30,667 25,108 61,058 49,460
Other        
Disaggregation of Revenue [Line Items]        
Revenues 3,912 2,848 7,737 5,058
Operating Segments | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Revenues 32,157 26,521 64,022 52,213
Net investment income (loss) 300 205 653 369
Total revenues 32,475 26,747 64,711 52,624
Operating Segments | Health Care Benefits | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 30,654 25,095 61,033 49,434
Operating Segments | Health Care Benefits | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,521 1,447 3,025 2,821
Operating Segments | Health Services        
Disaggregation of Revenue [Line Items]        
Revenues 38,694 43,032 75,160 83,843
Net investment income (loss) (2) 0 (2) 0
Total revenues 42,171 46,215 82,456 90,806
Operating Segments | Health Services | Pharmacy network        
Disaggregation of Revenue [Line Items]        
Total revenues 21,848 27,477 42,312 55,069
Operating Segments | Health Services | Mail & specialty        
Disaggregation of Revenue [Line Items]        
Total revenues 17,651 17,229 34,913 33,374
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 2,674 1,509 5,233 2,363
Operating Segments | Health Services | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 39,499 44,706 77,225 88,443
Operating Segments | Health Services | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2,674 1,509 5,233 2,363
Operating Segments | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Revenues 19,974 19,079 39,612 37,505
Net investment income (loss) 0 1 0 (2)
Total revenues 29,838 28,784 58,563 56,706
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 24,013 22,614 46,797 44,394
Operating Segments | Pharmacy & Consumer Wellness | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,281 5,629 10,651 11,226
Operating Segments | Pharmacy & Consumer Wellness | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other        
Disaggregation of Revenue [Line Items]        
Revenues 544 540 1,115 1,088
Corporate/ Other | Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Revenues 15 15 29 30
Net investment income (loss) 96 68 197 241
Total revenues 111 83 226 271
Corporate/ Other | Corporate/ Other | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 13 13 25 26
Corporate/ Other | Corporate/ Other | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2 2 4 4
Intersegment Eliminations        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues (13,361) (12,908) (26,285) (26,208)
Intersegment Eliminations | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues (12,532) (12,258) (24,645) (24,990)
Intersegment Eliminations | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Other        
Disaggregation of Revenue [Line Items]        
Revenues $ (829) $ (650) $ (1,640) $ (1,218)